Novel analytical solutions for convolution in compartmental pharmacokinetic models and application to non-bioequivalent formulations

Autor: García, Mauricio A., González, Pablo M., Aceituno, Alexis, Al-Gousous, Jozef

Publikováno v: In European Journal of Pharmaceutical Sciences 1 November 2024 202

Corrigendum to Novel analytical solutions for convolution in compartmental pharmacokinetic models and application to non-bioequivalent formulations [European Journal of Pharmaceutical Sciences 202 (2024) 1–10/106892]

Autor: García, Mauricio A., González, Pablo M., Aceituno, Alexis, Al-Gousous, Jozef

Publikováno v: In European Journal of Pharmaceutical Sciences 1 December 2024 203

'Development of Fixed Dose Combination Products' Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy

Autor: Hens, Bart, Corsetti, Maura, Bermejo, Marival, Mitra, Amitava, Desai, Divyakant, Chilukuri, Dakshina Murthy, Aceituno, Alexis

The gastrointestinal (GI) tract is one of the most popular and used routes of drug product administration due to the convenience for better patient compliance and reduced costs to the patient compared to other routes. However, its complex nature pose

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ef72c337c341e50e82a0fbbfd8e65488

The effect of an autologous cellular gel-matrix integrated implant system on wound healing.

Autor: Weinstein-Oppenheimer, Caroline R.¹ caroline.weinstein@uvach.cl, Aceituno, Alexis R.², Brown, Donald I.³, Acevedo, Cristian⁴, Ceriani, Ricardo⁵, Fuentes, Miguel A.⁵, Albornoz, Fernando⁴, Henríquez-Roldán, Carlos F.^6,7, Morales, Patricio⁸, Maclean, Claudio⁹, Tapia, Sergio M.⁵, Young, Manuel E.⁴

Publikováno v: Journal of Translational Medicine. 2010, Vol. 8, p59-69. 11p.

"Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy.

Autor: Hens B; Department of Pharmaceutical & Pharmacological Sciences, KU Leuven, Herestraat 49, Gasthuisberg, Box 921, 3000, Leuven, Belgium. bart.hens@kuleuven.be., Corsetti M; NIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.; Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, UK., Bermejo M; Department Engineering Pharmacy Section, Miguel Hernandez University, San Juan de Alicante, 03550, Alicante, Spain., Löbenberg R; Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, T6G 2H7, Canada., González PM; Departamento de Farmacia, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Av Vicuña Mackenna, 4860, Santiago, Chile., Mitra A; Clinical Development, Sandoz, Inc. (A Novartis Division), Princeton, New Jersey, 08540, USA., Desai D; Drug Product Science and Technology, Bristol-Myers Squibb Company, New Brunswick, New Jersey, 08903-0191, USA., Chilukuri DM; Office of Clinical Pharmacology, Office of Translational Sciences, CDER, FDASilver Spring, US Food & Drug Administration (US FDA), Prince Georges Counties, Maryland, USA., Aceituno A; Subdepto. Biofarmacia y Equivalencia Terapéutica, Agencia Nacional de Medicamentos (ANAMED), Instituto de Salud Pública de Chile, Santiago, Chile y Facultad de Farmacia, Universidad de Valparaíso, Valparaíso, Chile.

Publikováno v: The AAPS journal [AAPS J] 2019 Jun 06; Vol. 21 (4), pp. 75. Date of Electronic Publication: 2019 Jun 06.